デフォルト表紙
市場調査レポート
商品コード
1347666

神経刺激装置市場:世界の産業動向、シェア、市場規模、成長、機会、2023-2028年予測

Neurostimulation Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 145 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
神経刺激装置市場:世界の産業動向、シェア、市場規模、成長、機会、2023-2028年予測
出版日: 2023年09月04日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要:

神経刺激装置の世界市場規模は2022年に79億米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて11.9%の成長率(CAGR)を示し、2028年までに148億米ドルに達すると予測しています。

神経刺激装置は、人間の脳の特定部位に電気信号を送ることができるプログラム可能な医療用送信機です。また、患者の体内の自律神経系、中枢神経系、末梢神経系の活動を刺激、抑制、修正、調整、変更するためにも使用されます。これは主に、運動障害、慢性疼痛、てんかんといったさまざまな医学的疾患の治療に役立ちます。また、神経補装具、補聴器、人工視覚、義肢、ブレイン・マシン・インターフェイスの操作にも利用されています。神経刺激装置には、埋め込み型と外付け型があります。

神経障害や生活習慣病が増加していることや、世界中で老年人口が急増していることは、市場の成長を促す主な要因のひとつです。さらに、患者の間で低侵襲(MI)手技への嗜好が高まっていることも、市場の成長を後押ししています。例えば、脳深部刺激療法(DBS)は、神経刺激装置を用いて脳回路の特定の場所に電気信号を送るMI手技です。これはパーキンソン病やアルツハイマー病など、さまざまな変性疾患の治療に役立ちます。さらに、神経系を電子的に刺激して視力を回復させたり、麻痺後の運動動作を回復させたりする装置の開発など、技術の進歩も市場に明るい見通しをもたらしています。医療業界の著しい成長、医療費の増加、広範な研究開発(R&D)活動など、その他の要因も今後数年間の市場を牽引すると予測されます。

本レポートで回答した主な質問

  • 2022年の神経刺激装置の世界市場規模は?
  • 2023~2028年の世界の神経刺激装置市場の予想成長率は?
  • 神経刺激装置の世界市場を牽引する主要因は?
  • COVID-19が世界の神経刺激装置市場に与えた影響は?
  • 神経刺激装置の世界市場における装置タイプ別の区分は?
  • 神経刺激装置の世界市場の用途別区分は?
  • 神経刺激装置の世界市場のエンドユーザー別の区分は?
  • 神経刺激装置の世界市場における主要地域は?
  • 神経刺激装置の世界市場における主要プレイヤー/企業は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 神経刺激装置の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:刺激タイプ別

  • 内部刺激
    • 市場動向
    • 市場予測
  • 外部刺激
    • 市場動向
    • 市場予測

第7章 市場内訳:デバイスタイプ別

  • SCS(脊髄刺激)デバイス
    • 市場動向
    • 市場予測
  • DBS(脳深部刺激)デバイス
    • 市場動向
    • 市場予測
  • SNS(仙骨神経刺激)デバイス
    • 市場動向
    • 市場予測
  • VNS(迷走神経刺激)機器
    • 市場動向
    • 市場予測
  • GES(胃電気刺激)デバイス
    • 市場動向
    • 市場予測
  • 経皮的電気神経刺激デバイス
    • 市場動向
    • 市場予測
  • 経頭蓋磁気刺激装置
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳:用途別

  • 疼痛管理
    • 市場動向
    • 市場予測
  • てんかん
    • 市場動向
    • 市場予測
  • 本態性振戦
    • 市場動向
    • 市場予測
  • 尿失禁と便失禁
    • 市場動向
    • 市場予測
  • うつ病
    • 市場動向
    • 市場予測
  • ジストニア
    • 市場動向
    • 市場予測
  • パーキンソン病
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳:エンドユーザー別

  • リハビリセンター
    • 市場動向
    • 市場予測
  • 病院
    • 市場動向
    • 市場予測
  • 診療所
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳:地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

  • 概要
  • インバウンド物流
  • オペレーション
  • アウトバウンド・ロジスティクス
  • マーケティングとセールス
  • ポストセールスサービス

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格指標

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Biocontrol Medical
    • Boston Scientific Corporation
    • Cyberonics Inc.
    • Medtronic Inc.
    • Neuronetics Inc.
    • Neuropace Inc.
    • Neurosigma Inc.
    • Nevro Corporation
    • ST. Jude Medical Inc.
    • Synapse Biomedical Inc.
図表

List of Figures

  • Figure 1: Global: Neurostimulation Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Neurostimulation Devices Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Neurostimulation Devices Market: Breakup by Stimulation Type (in %), 2022
  • Figure 4: Global: Neurostimulation Devices Market: Breakup by Device Type (in %), 2022
  • Figure 5: Global: Neurostimulation Devices Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Neurostimulation Devices Market: Breakup by End-User (in %), 2022
  • Figure 7: Global: Neurostimulation Devices Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Neurostimulation Devices Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 9: Global: Neurostimulation Devices (Internal Stimulation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Neurostimulation Devices (Internal Stimulation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Neurostimulation Devices (External Stimulation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Neurostimulation Devices (External Stimulation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Neurostimulation Devices (Spinal Cord Stimulation Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Neurostimulation Devices (Spinal Cord Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Neurostimulation Devices (Deep Brain Stimulation Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Neurostimulation Devices (Deep Brain Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Neurostimulation Devices (Sacral Nerve Stimulation Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Neurostimulation Devices (Sacral Nerve Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Neurostimulation Devices (Vagus Nerve Stimulation Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Neurostimulation Devices (Vagus Nerve Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Neurostimulation Devices (Gastric Electrical Stimulation Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Neurostimulation Devices (Gastric Electrical Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Neurostimulation Devices (Transcutaneous Electrical Nerve Stimulation Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Neurostimulation Devices (Transcutaneous Electrical Nerve Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Neurostimulation Devices (Transcranial Magnetic Stimulation Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Neurostimulation Devices (Transcranial Magnetic Stimulation Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Neurostimulation Devices (Other Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Neurostimulation Devices (Other Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Neurostimulation Devices (Pain Management) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Neurostimulation Devices (Pain Management) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Neurostimulation Devices (Epilepsy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Neurostimulation Devices (Epilepsy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Neurostimulation Devices (Essential Tremors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Neurostimulation Devices (Essential Tremors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Neurostimulation Devices (Urinary and Fecal Incontinence) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Neurostimulation Devices (Urinary and Fecal Incontinence) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Neurostimulation Devices (Depression) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Neurostimulation Devices (Depression) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Neurostimulation Devices (Dystonia) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Neurostimulation Devices (Dystonia) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Neurostimulation Devices (Parkinson's Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Neurostimulation Devices (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Neurostimulation Devices (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Neurostimulation Devices (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Global: Neurostimulation Devices (Rehabilitation Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Global: Neurostimulation Devices (Rehabilitation Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Global: Neurostimulation Devices (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Global: Neurostimulation Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Global: Neurostimulation Devices (Medical Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Global: Neurostimulation Devices (Medical Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Global: Neurostimulation Devices (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Global: Neurostimulation Devices (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: North America: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: North America: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: United States: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: United States: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Canada: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Canada: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Europe: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Europe: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Germany: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Germany: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: France: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: France: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: United Kingdom: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: United Kingdom: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Italy: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Italy: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Spain: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Spain: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Russia: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Russia: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Others: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Asia Pacific: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Asia Pacific: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: China: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: China: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Japan: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Japan: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: India: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: India: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: South Korea: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: South Korea: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Australia: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Australia: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Indonesia: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Indonesia: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Others: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Latin America: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Latin America: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 93: Brazil: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 94: Brazil: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 95: Mexico: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 96: Mexico: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 97: Others: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 98: Others: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 99: Middle East and Africa: Neurostimulation Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 100: Middle East and Africa: Neurostimulation Devices Market: Breakup by Country (in %), 2022
  • Figure 101: Middle East and Africa: Neurostimulation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 102: Global: Neurostimulation Devices Industry: SWOT Analysis
  • Figure 103: Global: Neurostimulation Devices Industry: Value Chain Analysis
  • Figure 104: Global: Neurostimulation Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Neurostimulation Devices Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Neurostimulation Devices Market Forecast: Breakup by Stimulation Type (in Million US$), 2023-2028
  • Table 3: Global: Neurostimulation Devices Market Forecast: Breakup by Device Type (in Million US$), 2023-2028
  • Table 4: Global: Neurostimulation Devices Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Neurostimulation Devices Market Forecast: Breakup by End-User (in Million US$), 2023-2028
  • Table 6: Global: Neurostimulation Devices Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Neurostimulation Devices Market: Competitive Structure
  • Table 8: Global: Neurostimulation Devices Market: Key Players
目次
Product Code: SR112023A1892

Market Overview:

The global neurostimulation devices market size reached US$ 7.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 14.8 Billion by 2028, exhibiting a growth rate (CAGR) of 11.9% during 2023-2028.

A neurostimulation device is a programmable medical transmitter that can deliver electrical signals to the specific parts of the human brain. It is also used to stimulate, inhibit, modify, regulate and alter the activity of the autonomous, central and peripheral nervous systems in the patient's body. This primarily aids in the treatment of various medical ailments, such as movement disorders, chronic pain and epilepsy. It is also utilized in the operation of neural prosthetics, hearing aids, artificial vision, artificial limbs and brain-machine interfaces. Neurostimulation devices can be both implantable or externally placed.

The rising instances of neurological and lifestyle-related disorders, along with the rapidly growing geriatric population across the globe, are among the key factors driving the growth of the market. Furthermore, the increasing preference for minimally invasive (MI) procedures among patients is also providing a boost to the market growth. For instance, deep brain stimulation (DBS) is an MI procedure that uses neurostimulation devices to deliver electrical signals to a specific spot in the brain circuits. This aids in treating various degenerative disorders, such as Parkinson's and Alzheimer's disease. Additionally, technological advancements, including the development of devices that can electronically stimulate the nervous system to restore vision and regain post-paralysis motor movements, are creating a positive outlook for the market. Other factors, including significant growth in the medical industry, increasing healthcare expenditure and extensive research and development (R&D) activities, are projected to drive the market in the upcoming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global neurostimulation devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on stimulation type, device type, application and end-user.

Breakup by Stimulation Type:

Internal Stimulation

External Stimulation

Breakup by Device Type:

SCS (Spinal Cord Stimulation) Devices

DBS (Deep Brain Stimulation) Devices

SNS (Sacral Nerve Stimulation) Devices

VNS (Vagus Nerve Stimulation) Devices

GES (Gastric Electrical Stimulation) Devices

Transcutaneous Electrical Nerve Stimulation Devices

Transcranial Magnetic Stimulation Devices

Others

Breakup by Application:

Pain Management

Epilepsy

Essential Tremors

Urinary and Fecal Incontinence

Depression

Dystonia

Parkinson's Disease

Others

Breakup by End-User:

Rehabilitation Centers

Hospitals

Medical Clinics

Others

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Biocontrol Medical, Boston Scientific Corporation, Cyberonics Inc., Medtronic Inc., Neuronetics Inc., Neuropace Inc., Neurosigma Inc., Nevro Corporation, ST. Jude Medical Inc., Synapse Biomedical Inc., etc

Key Questions Answered in This Report

  • 1. What was the size of the global neurostimulation devices market in 2022?
  • 2. What is the expected growth rate of the global neurostimulation devices market during 2023-2028?
  • 3. What are the key factors driving the global neurostimulation devices market?
  • 4. What has been the impact of COVID-19 on the global neurostimulation devices market?
  • 5. What is the breakup of the global neurostimulation devices market based on the device type?
  • 6. What is the breakup of the global neurostimulation devices market based on the application?
  • 7. What is the breakup of the global neurostimulation devices market based on the end-user?
  • 8. What are the key regions in the global neurostimulation devices market?
  • 9. Who are the key players/companies in the global neurostimulation devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Neurostimulation Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Stimulation Type

  • 6.1 Internal Stimulation
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 External Stimulation
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Device Type

  • 7.1 SCS (Spinal Cord Stimulation) Devices
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 DBS (Deep Brain Stimulation) Devices
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 SNS (Sacral Nerve Stimulation) Devices
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 VNS (Vagus Nerve Stimulation) Devices
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 GES (Gastric Electrical Stimulation) Devices
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Transcutaneous Electrical Nerve Stimulation Devices
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Transcranial Magnetic Stimulation Devices
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Pain Management
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Epilepsy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Essential Tremors
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Urinary and Fecal Incontinence
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Depression
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Dystonia
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Parkinson's Disease
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast
  • 8.8 Others
    • 8.8.1 Market Trends
    • 8.8.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Rehabilitation Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Medical Clinics
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Germany
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 France
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 United Kingdom
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 Italy
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Spain
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Russia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 China
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 Japan
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 India
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 South Korea
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Australia
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Indonesia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

  • 12.1 Overview
  • 12.2 Inbound Logistics
  • 12.3 Operations
  • 12.4 Outbound Logistics
  • 12.5 Marketing and Sales
  • 12.6 Post Sales Services

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Biocontrol Medical
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Boston Scientific Corporation
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Cyberonics Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Medtronic Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Neuronetics Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Neuropace Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Neurosigma Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Nevro Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 ST. Jude Medical Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Synapse Biomedical Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio